Latest News

Tools and Resources Drug Updates

Pharmacist's Application to Practice: Elranatamab-bcmm

Emily Lo, PharmD Candidate and Chung-Shien Lee, PharmD, BCPS, BCOP at St John’s University College of Pharmacy and Health Sciences write about Elranatamab-bcmm).

Tools and Resources Drug Updates

Pharmacist’s Application to Practice: Talquetamab-tgvs

Marguerite Courtney, PharmD Candidate 2024 and Bradley Yelvington, PharmD, BCOP from University of Tennessee discuss talquetamab-tgvs

Tools and Resources Drug Updates

Pharmacist's Application to Practice: Epcoritamab-bysp

Shaniya Pleasant, PharmD/MHCI Candidate and Bradley Yelvington, PharmD, BCOP from Vanderbilt University Medical Center write about epcoritamab-bysp

Tools and Resources Late Breaking News

Immune Checkpoint Inhibitors Make Great Strides in Hepatocellular Carcinoma

STRIDE presents an alternative first-line choice for patients with unresectable HCC with a manageable side effect profile and a 22% reduction in risk of death over sorafenib

Tools and Resources Drug Updates

Pharmacist's Application to Practice: Retifanlimab-dlwr

Bernard Marini, PharmD, BCOP, Clinical Pharmacist Specialist at University of Michigan College of Pharmacy writes about Retifanlimab-dlwr.

Tools and Resources Drug Updates

Pharmacist's Application to Practice: Pirtobrutinib

Andy Hawn, 2025 PharmD Candidate and Erin Kelley, PharmD, BCOP at the Masonic Cancer Clinic Infusion Pharmacy write about Pirtobrutinib

Tools and Resources Late Breaking News

BPS Announces Professional Development Programs Approved for the Recertification of Board-Certified Pharmacists beginning in January 2024

BPS Announces Professional Development Programs Approved for the Recertification of Board-Certified Pharmacists beginning in January 2024

Tools and Resources Drug Updates

Pharmacist's Application to Practice: Mosunetuzumab

Bernard Marini, PharmD, BCOP Clinical Pharmacist Specialist – Hematology/Oncology Clinical Associate Professor University of Michigan College of Pharmacy writes about Mosunetuzumab.

Imaging scan of lung cancer
Tools and Resources Drug Updates

Pharmacist Application to Practice: Adagrasib

Sam Palmatier, Pharmacy Intern and Jeff Engle, PharmD, MS, Oncology Pharmacy Manager at Fairview Cancer Clinic – Edina write about

Tools and Resources Drug Updates

Pharmacist's Application to Practice: Olutasidenib

Bernard Marini, PharmD, BCOP, Clinical Pharmacist at University of Michigan College of Pharmacy writes about Olutasidenib

Scan of human lungs
Tools and Resources Drug Updates

Pharmacist's Application to Practice: Tremelimumab

Tremelimumab (IMJUDO, AztraZeneca Pharmaceuticals) approved November 10, 2022 for metastatic non-small cell lung cancer and approved October 24, 2022 for unresectable hepatocellular carcinoma

Tools and Resources Drug Updates

Pharmacist’s Application to Practice: Teclistamab-cqyv

Gavyn Walsh, PD3 Oncology Pharmacy Intern and Erin Kelley, PharmD, BCOP at M Health Fairview Masonic Cancer Clinic write about teclistamab-cqyv